Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Auric Goldfinger's Short List -- Ignore unavailable to you. Want to Upgrade?

To: StockDung who wrote (13299)	7/6/2004 10:27:24 PM
From: SEC-ond-chance	Respond to of 19428

Heard there are no prices on the menu. When you go to the cashier he says MArket or LimIt Order? I got the Bluepoint sandwich for $9500 but I get the last laugh.

To: StockDung who wrote (13299)	7/6/2004 11:19:26 PM
From: SEC-ond-chance	Read Replies (2) \| Respond to of 19428

June 28, 2004 01:00 AM US Eastern Timezone MAS Capital Filed a $1.5 Million Lawsuit Against Biodelivery Sciences International, Inc. for Damages EVANSVILLE, Ind.--(BUSINESS WIRE)--June 28, 2004--MAS Capital Inc. today announced that a lawsuit against Biodelivery Sciences International, Inc. ("Biodelivery", NasdaqSC symbol "BDSI") has been filed. MAS Capital filed a lawsuit against Biodelivery (Cause No. 82C01-0404-PL-280) in the Vanderburgh Circuit Court, State of Indiana on April 19, 2004. MAS Capital made allegations against Biodelivery for unjust enrichment, constructive contract, quasi-contract, contract implied at law, and quantum meruit. MAS Capital is seeking $1,575,000 in damages, plus costs, prejudgement interest and post-judgment interest. The lawsuit was removed to U.S. District Court, Southern District of Indiana, Evansville Division on June 8, 2004 (CASE No. 3:04-cv-0092-DFH-WGH). MAS Financial, which was a wholly owned subsidiary of MAS Capital, provided valuable consulting and capital raising services to Biodelivery from December 2000 to December 2001. Through the efforts of MAS Financial, Biodelivery completed a $10.5 million public offering through two underwriters. Biodelivery refused to pay for services provided by MAS Financial. In connection with a separate transaction, MAS Capital Inc. arranged a merger of its former subsidiary, MAS Acquisition XXIII Corp., a public shell company, with Biodelivery. As a result MAS Capital owned 327,600 shares of common stock and an option to purchase 100,000 shares of common stock of Biodelivery, all of which was sold back to Hopkins Capital Group II, LLC, an entity controlled by Dr. Francis O'Donnell, Chairman and CEO of Biodelivery on March 29, 2002 for $150,696 for a twelve month Promissory Note prior to the completion of the public offering. MAS Capital provides financing to Hopkins Capital Group II, LLC by extending the March 29, 2002 twelve month Promissory Note several times charging interest and penalties. The latest amended Promissory Note "provide that all remaining principal and interest shall be paid in two installments on December 31, 2004 for $39,980.80 and June 30, 2005 for $52,000. Hopkins Capital Group II, LLC agreed to pay $5,000 monthly penalty for each month past due and has previously paid MAS Capital Inc. a total of $20,000 in penalties. MAS Capital is a closely held financial company. More information about MAS Capital is available at mascapital.com. home.businesswire.com